- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07830680
Physiopathology of Behavioral Addictions and Biomarkers (MiRACle)
Physiopathology of Behavioral Addictions and Biomarkers: microRNAs Implication - MiRACle : a Pilot Study.
The goal of this observational study is to evaluate the expression of miR-10a-5p in the blood in patients with sexual addiction or food addiction. The main question it aims to answer is : To determine whether adults patients with SA or FA exhibit a distinct blood miR-10a-5p expression profile compared with matched healthy controls.
For all participants, one blood sample will be collected.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Pr Caroline Victorri-Vigneau
- Telefonnummer: 02.40.84.76.20
- E-mail: marie.bronnec@chu-nantes.fr
Studiesteder
-
-
-
Nantes, Frankrig
- Nantes University Hospital
-
Kontakt:
- Gaëlle CHALLET
- Telefonnummer: 02.40.84.76.20
- E-mail: gaelle.bouju@chu-nantes.fr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Patients with food or sexual addiction, compared with age- and sex-matched healthy controls with no current addictive disorder.
Beskrivelse
Inclusion criteria
For patients with FA:
- Male and females ≥ 18 years old
- Already in care or newly initiating care
- Participating to EVALADD cohort
- Current diagnosis of FA
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with FA:
- Male and females ≥ 18 years old
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For patients with SA:
- Male ≥ 18 years old
- Already in care or newly initiating care
- Participating to EVALADD cohort
- Current diagnosis of SA
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with SA:
- Male ≥ 18 years old
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
Exclusion Criteria :
For patients with FA:
- Presence of a current diagnosis of SA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Pregnancy or breastfeeding woman
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
For patients with SA:
- Presence of a current diagnosis of FA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
For healthy controls:
- Without a current diagnosis of FA
- Without a current diagnosis of SA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Pregnancy or breastfeeding woman
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: CASE_CONTROL
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Patients with addiction
Patients with food addiction (FA) or sexual addiction |
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube |
|
Healthy controls
Healthy controls matched on sex and age to patients with food addiction or sexual addiction |
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Blood miR-10a-5p expression
Tidsramme: 3 months
|
The concentration of each miR-enriched fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls. |
3 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Blood additional circulating miRs expression
Tidsramme: 3 months
|
The concentration of circulating miRs fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls. |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and age |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and sex |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and duration of addiction |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and severity of addiction |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and tobacco-use |
3 months
|
|
Clinical Characteristics
Tidsramme: 3 months
|
Association between blood expression levels of circulating miRs and psychiatric disorders |
3 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Psykiske lidelser
- Seksuelle dysfunktioner, psykologiske
- Adfærd, vanedannende
- Kompulsiv adfærd
- Impulsiv adfærd
- Ernærings- og spiseforstyrrelser
- Seksuelle og kønslidelser
- Opførsel
- Madafhængighed
- Kompulsiv seksuel adfærdsforstyrrelse
- Undersøgelsesteknikker
- Håndtering af eksemplar
- Kliniske laboratorieteknikker
- Diagnostiske teknikker og procedurer
- Diagnose
- Punkteringer
- Kirurgiske procedurer, operative
- Blodprøveopsamling
Andre undersøgelses-id-numre
- RC26_0091
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .